Prostate Cancer and Prostatic Diseases

Articles Available on Medscape

• Variation in the Use of Postoperative Radiotherapy Among High-Risk Patients Following Radical Prostatectomy
  A new study finds inconsistencies in the utilization of post-radical prostatectomy radiotherapy. What accounts for the variances?

  August 10, 2016

• Non-Surgically Related Causes of Erectile Dysfunction After Bilateral Nerve-Sparing Radical Prostatectomy
  Erectile dysfunction is a common side effect of radical prostatectomy in prostate cancer patients -- but certain non-surgically related aspects may also impact erectile function recovery.

  July 11, 2016

• Patient Experience in the Treatment of Metastatic Castration-Resistant Prostate Cancer
  A new study provides insight into the health-related quality of life impacts of new treatment options for metastatic castration-resistant prostate cancer -- from the patient's perspective.

  June 10, 2016

• Association of Diet and Lifestyle With Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Pain Severity
  Certain dietary and lifestyle factors may contribute to pain severity in chronic prostatitis/chronic pelvic pain syndrome. What are they?

  May 10, 2016

• Prostatectomy at High-Volume Centers Improves Outcomes and Lowers the Costs of Care for Prostate Cancer
  Are prostatectomies performed at high-volume centers tied to better outcomes in prostate cancer? What are the economic implications?

  April 08, 2016

Table of Contents

2018 -

• Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence? 

  October 02, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning. 

  October 02, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer. 

  October 02, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy. 

  October 02, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Impact of age on exposure to oral antiandrogen therapies in clinical practice. 

  October 02, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• PTEN status assessment in the Johns Hopkins active surveillance cohort. 

  October 02, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Prostate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis. 

  October 02, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Updates in advanced prostate cancer 2018. 

  October 02, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Nocturia and associated mortality: observational data from the REDUCE trial. 

  September 13, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data. 

  September 13, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer. 

  September 13, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer. 

  September 05, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Practice patterns of primary EBRT with and without ADT in prostate cancer treatment. 

  August 31, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage. 

  August 31, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort. 

  August 31, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer. 

  August 31, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Estrogens and prostate cancer. 

  August 21, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• BRCAness and prostate cancer: diagnostic and therapeutic considerations. 

  August 21, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations. 

  August 21, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Bipolar plasma enucleation of the prostate vs. open prostatectomy in large benign prostatic hyperplasia: a single centre 3-year comparison. 

  August 21, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study. 

  August 20, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• MRI in active surveillance: a critical review. 

  August 16, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapies. 

  August 16, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis. 

  August 14, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance. 

  August 14, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Incidence and risk factors of suicide after a prostate cancer diagnosis: a meta-analysis of observational studies. 

  August 14, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Prostate cancer risk factors in black and white men in the NIH-AARP Diet and Health Study. 

  August 14, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years. 

  August 13, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Fructose and prostate cancer: toward an integrated view of cancer cell metabolism. 

  August 13, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Use of high and very high dose radiotherapy after radical prostatectomy for prostate cancer in the United States. 

  August 07, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test. 

  August 07, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Relative telomere length and prostate cancer mortality. 

  August 06, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Reply to Letter to the Editor re: 'Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting'. 

  August 06, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial. 

  July 23, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indications. 

  July 23, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• The natural history of prostate cancer on MRI: lessons from an active surveillance cohort. 

  July 23, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. 

  July 09, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Targets missed: predictors of MRI-targeted biopsy failing to accurately localize prostate cancer found on systematic biopsy. 

  July 09, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Harnessing the potential of therapeutic agents to safeguard bone health in prostate cancer. 

  July 09, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: a systematic review and meta-analysis. 

  July 09, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. 

  July 09, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study. 

  July 09, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Statin use and time to progression in men on active surveillance for prostate cancer. 

  June 06, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Addition of abiraterone, docetaxel, bisphosphonate, celecoxib or combinations to androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC): a network meta-analysis. 

  June 06, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement. 

  May 09, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study. 

  May 02, 2018

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]